The meeting of the EAU Section of Urological Imaging (ESUI) is a progressive, technology- and innovation-rich initiative which is of increasing importance to all urologists. ESUI Chairman Prof. Jochen Walz comments on the plans for the 2014 edition of this event, to be held on November 13, 2014.What are this year’s hottest topics in imaging?
During the meeting our emphasis will lie with the latest developments in the diagnosis of urological pathologies including Ultrasound, MRI and PET/CT, as well as addressing the latest developments in interventional imaging and image-guided therapies. Moreover, the single day meeting will provide detailed clinical knowledge about how to apply and use these techniques. This will close the gap between preliminary experiences in selected centers and the early and broad application of these techniques in daily practice. Also the EMUC congress starting the day after at the same location, will pick up the topic of imaging with a series of complementary presentations.
Why is this a “must-attend” event for urologists?
Imaging will play a huge role in the future. Urologist need to be familiar with these new technologies and developments to maintain their level of competence: Our meeting is simply the best place to learn about these technologies and to implement them later into practice.
How is the field of urological imagining changing and what can we expect in the next year or two?
We expect the publication of several prospective studies, which are likely to change our current standards. Especially in the diagnosis of prostate cancer changes are awaited, mainly based on standardization of tests leading to increased reliability, efficacy and reproducibility
The 3rd Meeting of the EAU Section of Urological Imaging will take place in conjunction with the 6th European Multidisciplinary Meeting on Urological Cancers (EMUC). Interested parties can register and submit abstracts to the combined event or the ESUI Meeting separately. More details are available on the ESUI Meeting and EMUC websites.